Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

✍ Scribed by Miguel, Jesus San; Weisel, Katja; Moreau, Philippe; Lacy, Martha; Song, Kevin; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Banos, Anne; Oriol, Albert; Alegre, Adrian; Chen, Christine; Cavo, Michele; Garderet, Laurent; Ivanova, Valentina; Martinez-Lopez, Joaquin; Belch, Andrew; Palumbo, Antonio; Schey, Stephen; Sonneveld, Pieter; Yu, Xin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed; Dimopoulos, Meletios

• Book ID: 121269191
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 374 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70380-2